PRDM2 and cancer: Our results strongly suggest that RIZ2 is a promising candidate oncogene in cancer development; however, additional attempts to discover cell partners interacting with RIZ2 are warranted to elucidate how the deregulation of RIZ2 prompts cell growth, survival, and organoid formation.